OGT Offers New Solid Tumour Panel Sequencing Service with Free AnalysisOxford Gene Technology Ltd

News

OGT Offers New Solid Tumour Panel Sequencing Service with Free Analysis
22 May 2013

Oxford Gene Technology’s (OGT) new SureSeq™ Solid Tumour Panel Sequencing Service utilizes a 58-gene, full coding region enrichment panel designed in collaboration with leading cancer researchers to deliver highly specific and sensitive detection of novel and known somatic variations from fresh, frozen and FFPE tissue samples.

The SureSeq Solid Tumour Panel Sequencing Service delivers:
• Flexible discovery — Broad gene content with option to incorporate additional genes of your choice
• Accurate — Enhanced bait design delivering increased uniformity of coverage for all target regions, enabling highly sensitive detection
• Research-validated — Confident detection of all variants in a blind study using FFPE tumour samples
• Clear reporting — Easy-to-use, interactive report delivers rapid access to meaningful results, without the requirement for local bioinformatics support

The SureSeq Solid Tumour Panel Sequencing Service utilizes the OGT optimized cancer panel based on Agilent SureSelect™ capture technology with sequencing on an Illumina HiSeq or MiSeq platform. The service starts with sample submission, continuing through capture and sequencing, before completing with generation of an interactive report that delivers rapid access to meaningful results.

Request Info

Company website